ArticleFrontiers in oncology2022
Anlotinib Downregulates RGC32 Which Provoked by Bevacizumab.
Zhujun Liu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
3 papers cite it
this papercites it
ArticleFrontiers in oncology2022
Zhujun Liu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.